Albert Hofman, MD, PhD, is chair of the Department of Epidemiology and the Stephen B. Kay Family Professor of Public Health and Clinical Epidemiology at the Harvard T.H. Chan School of Public Health in Boston, Massachusetts (USA). Dr. Hofman was the chair of the Department of Epidemiology of the Erasmus Medical Center at Erasmus University Rotterdam, The Netherlands, from 1988 until 2016. He has been science director of the graduate…
Wayne Koff, PhD, is the founding president and CEO of the Human Immunome Project. Prior to joining the Project, Koff served as chief scientific officer and senior vice president of research and development at the International AIDS Vaccine Initiative (IAVI) in New York City (1999-2016), leading IAVI’s research and development program. At IAVI, his accomplishments included developing multiple HIV vaccines through clinical trials; establishing state-of-the-art laboratories in the U.S., Europe,…
Jaap Goudsmit is a Dutch scientist and nonfiction writer, best known for his research on AIDS and influenza. In 1978, Jaap Goudsmit received his MD degree with honors from the University of Amsterdam. He was awarded a Fogarthy Fellowship of the National Institutes of Health in the U.S. and started to study the transmissibility of Alzheimer’s disease at the laboratory of D. Carleton Gajdusek, who was awarded the Nobel Prize…
Ted Schenkelberg, MBA, MPH, brings more than 15 years of experience applying business management principles to advance biomedical and global health priorities across the nonprofit and for-profit sectors. He is co-founder of the Human Immunome Project, where he currently serves as chief operating officer. Previously, Schenkelberg worked as a strategic consultant in the global health and biotech space, including work for a leading Indian health system and national initiatives on…
Galit Alter is a professor of medicine at Harvard Medical School and a group leader at the Ragon Institute of MGH, MIT, and Harvard. Alter’s work focuses on the development of systems biology tools to define the correlates of immunity against infectious diseases that ravage the globe. To this end, Alter developed a novel, ever-evolving approach to probing humoral immunity that she termed “systems serology.” Alter uses this novel -omics…
Sarah Fortune is the John LaPorte Given Professor of Immunology and Infectious Diseases and chair of the Department of Immunology and Infectious Diseases at the Harvard T.H. Chan School of Public Health and director of the TB Research Program at the Ragon Institute of MGH, Harvard, and MIT. She received a bachelor of science degree in biology from Yale University and a medical degree from Columbia University’s College of Physicians…
Sonia Hernandez-Diaz, M.D., Dr.P.H. a physician and epidemiologist, is the Director of the Pharmacoepidemiology Program and Professor of Epidemiology at the Harvard T.H. Chan School of Public Health. Her area of interest is drug safety evaluation from non-randomized data, with a special emphasis on the design, conduct, and analysis of studies in pregnant women and their infants. She has experience developing and applying methods to case-control surveillance, case-only, and ad…
Wouter Koudstaal, PhD, brings over 15 years of R&D experience in academic, biotech, and pharma settings having focused on the discovery and early (preclinical) development of vaccines and therapeutics in the fields of infectious diseases and neuroscience at Crucell, a Dutch biotech company, and Janssen. Moreover, Koudstaal conducted part of his research at the Beth Israel Deaconess Medical Center (BIDMC) of Harvard Medical School in Boston and at Imperial College,…
Nikita Mahulkar joined the Human Immunomics Initiative in June of 2020. Prior to this, she received a bachelor’s degree in business administration from Suffolk University. After graduating, she joined the Harvard T.H. Chan School of Public Health as interim program coordinator for the Center for Communicable Disease Dynamics in 2019. Nikita served as the Program Coordinator for the Human Immunomics Initiative from 2020 through the fall of 2022, during which…
Anita van den Biggelaar, PhD, is trained as an immunologist and epidemiologist and has always worked in the fields of immunoepidemiology (“applied immunology”), infectious diseases, and vaccinology. Her MSc (1996, with distinction) and PhD (2002, with distinction) were both in the field of immunoparasitology (helminths), involving field trials in Indonesia and Gabon (Central Africa). After a two-year postdoc in the Netherlands, where she skilled her epidemiology and conducted field studies…